The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Open accessAbstract
Background& Aims There is not much data available about the prevalence or effects of cirrhosis in patients with hepatocellular carcinoma (HCC) from viral hepatitis. We compared patients with HCC and hepatitis B virus (HBV) or hepatitis C virus (HCV) infections to determine the proportions of cirrhosis in each group, virologic and tumor characteristics, and overall survival. Methods This analysis includes patients with HBV (n=64) or HCV (n=118) infection who were diagnosed with HCC at the Mayo Clinic in Rochester MN from 1994 to 2008; groups were matched for age and sex. The diagnosis of cirrhosis was based on histology and, if histologic information was insufficient or unavailable, clinical indicators that included ascites or varices, thrombocytopenia or splenomegaly, and radiographic configuration of cirrhosis. Virologic characteristics, tumor stage, and patient survival were also assessed. Results The prevalence of histologic cirrhosis was 88% among patients with HBV infection and 93% among those with HCV infection (P=0.46). When the most inclusive criteria for cirrhosis were applied, cirrhosis was present in 94% of patients with HBV and 97% with HCV (P=0.24). Among HCV patients, 5.2% were negative for HCV RNA following antiviral treatment; 63.4% of HBV patients had HBV DNA < 2000 u/ml with or without treatment. Patients with HBV tended to have less surveillance and more advanced stages of HCC, without differences in survival from those with HCV infection (P=0.75). Conclusion Most patients with HCC and chronic viral hepatitis had evidence of cirrhosis, including those with HBV infection and those without active viral replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Hepatocellular carcinoma: a global view
Yang, J. D., & Roberts, L. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.100 · Cited by 1,286
Self-citationHepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
(2000) · Hepatology · doi:10.1053/he.2000.5628 · Cited by 521
Lin, S.-M., Sheen, I.-S., Chien, R.-N., Chu, C.-M., & Liaw, Y.-F. (1999) · Hepatology · doi:10.1002/hep.510290312 · Cited by 444
Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M., & Omata, M. (1995) · Hepatology · doi:10.1002/hep.1840210308 · Cited by 432
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
Yuen, M.-F., Yuan, H.-J., Wong, D. K.-H., Yuen, J. C.-H., Wong, W.-M., Chan, A. O.-O., Wong, B. C.-Y., Lai, K.-C., & Lai, C.-L. (2005) · Gut · doi:10.1136/gut.2005.065136 · Cited by 375
Shiratori, Y., Shiina, S., Imamura, M., Kato, N., Kanai, F., Okudaira, T., Teratani, T., Tohgo, G., Toda, N., Ohashi, M., et al. (1995) · Hepatology · doi:10.1002/hep.1840220403 · Cited by 365
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Cammà, C., Giunta, M., Andreone, P., & Craxı̀, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00005-8 · Cited by 356
Paterlini-Bréchot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D., & Bréchot, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206492 · Cited by 354
Chen, J., Yang, H., Iloeje, U. H., You, S., Lu, S., Wang, L., Su, J., Sun, C., Liaw, Y., & Chen, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.042 · Cited by 331
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B
van Zonneveld, M., Honkoop, P., Hansen, B. E., Niesters, H. G. M., Murad, S. D., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2004) · Hepatology · doi:10.1002/hep.20128 · Cited by 322
The role of cytokines in hepatocellular carcinoma
Budhu, A., & Wang, X. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506297 · Cited by 319
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
Yuen, M.-F., Seto, W.-K., Chow, D. H.-F., Tsui, K., Wong, D. K.-H., Ngai, V. W.-S., Wong, B. C.-Y., Fung, J., Yuen, J. C.-H., & Lai, C.-L. (2007) · Antiviral Therapy · doi:10.1177/135965350701200816 · Cited by 257
Bralet, M.-P., Régimbeau, J.-M., Pineau, P., Dubois, S., Loas, G., Degos, F., Valla, D., Belghiti, J., Degott, C., & Terris, B. (2000) · Hepatology · doi:10.1053/jhep.2000.9033 · Cited by 249
Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
Nishiguchi, S., Shiomi, S., Nakatani, S., Takeda, T., Fukuda, K., Tamori, A., Habu, D., & Tanaka, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03595-9 · Cited by 238
Valla, D.-C., Chevallier, M., Marcellin, P., Payen, J.-L., Trepo, C., Fonck, M., Bourliere, M., Boucher, E., Miguet, J.-P., Parlier, D., et al. (1999) · Hepatology · doi:10.1002/hep.510290616 · Cited by 211
The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma
Bonilla Guerrero, R., & Roberts, L. R. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.005 · Cited by 204
Self-citationMATSUMOTO, A., TANAKA, E., ROKUHARA, A., KIYOSAWA, K., KUMADA, H., OMATA, M., OKITA, K., HAYASHI, N., OKANOUE, T., & IINO, S. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.02.006 · Cited by 194
Hepadnaviral X protein: Review of recent progress
Benedict Yen, T. S. (1996) · Journal of Biomedical Science · doi:10.1007/bf02253575 · Cited by 163
Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma
Branda, M., & Wands, J. R. (2006) · Hepatology · doi:10.1002/hep.21196 · Cited by 117
Cited by
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Epidemiology of Hepatocellular Carcinoma: Consider the Population
Mittal, S., & El-Serag, H. B. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182872f29 · Cited by 1,076
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Chronic Hepatitis B Infection: A Review
Tang, L. S. Y., Covert, E., Wilson, E., & Kottilil, S. (2018) · JAMA · doi:10.1001/jama.2018.3795 · Cited by 657
Metadata
- Authors
- Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., & Roberts, L. R.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 9
- Issue
- 1
- Pages
- 64-70
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2087021985
- Cited by
- 266
- References
- 26
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.